French beauty giant L’Oréal reported weaker-than-expected third-quarter growth, with North American performance weighing on results. However, the company noted encouraging signs of recovery in China’s luxury beauty market, offering a glimmer of optimism after two years of slowdown.
CEO Nicolas Hieronimus said the Chinese beauty market expanded by about 3% in the quarter—its first growth in two years—driven by improving consumer sentiment. “One quarter doesn’t make a trend, but overall, the market has turned positive,” he told analysts, adding that L’Oréal outperformed the broader luxury beauty segment in China.
From July to September, total sales rose 4.2% to €10.3 billion ($12.01 billion), falling short of the 4.9% growth forecast by Visible Alpha. Excluding the impact of a new IT system rollout, underlying growth matched expectations at 4.9%. Analysts from Jefferies called the results “a notable miss versus high expectations.”
L’Oréal’s recent growth slowdown follows post-pandemic inflation stabilization in Western markets and cautious spending in China, where consumers have increasingly turned to local brands. Hieronimus acknowledged the brand is still lagging in China’s mass-market beauty segment with lines such as L’Oréal Paris and Maybelline, but noted gains in U.S. makeup sales.
The company continues to focus on innovation and acquisitions, particularly in fragrances, one of the fastest-growing beauty categories. Fragrance sales, which surged 11% in the first half, slowed to around 6% in Q3.
L’Oréal also announced a $4.7 billion deal to acquire Kering’s beauty division, including future rights to Gucci Beautyonce its license with Coty expires in 2028. Hieronimus suggested Gucci could rival Yves Saint Laurent, which generates nearly €3 billion annually. He added that the deal won’t affect potential investment talks with Armani, which had previously named L’Oréal as a preferred partner.


Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027
NIO CEO Says China’s Auto Industry Has Passed Its Golden Era Amid Weak Car Sales
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook
Universal Music Group Rejects Pershing Square Takeover Proposal
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs
Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results 



